HPV: Some Women are More Likely to Get Infected; CBCD Reviews the Medical Evidence
Industry: Health & Fitness
A medical review of HPV studies showed that up to 27% of all women are genetically susceptible to HPV infection. The CBCD recommends two natural HPV remedies.
New York (PRUnderground) October 9th, 2014
The risk of HPV infection is connected to a woman’s genetics. Dr. Koushik Chattopadhyay wrote in a comprehensive medical review of available data that “the genetic link to cervical cancer development is strongly supported by epidemiological studies.” (1) Dr. Chattopadhyay is from the Nelson R. Mandela School of Medicine in South Africa. The evidence shows that up to 27% of all women have a higher risk of developing HPV caused cervical cancer because of genetic factors. “A hereditary component of cervical tumors was detected in comparisons of twins and in a mother-daughter family study.” (1) First degree relatives of women with cervical cancer have more than twice the risk of developing cancer themselves. The CBCD recommends that HPV infected women take Novirin or Gene-Eden-VIR. The formula of these natural HPV remedies was designed to help the immune system target the latent virus.
Click to learn more about HPV symptoms.
The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against the HPV and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HPV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (2) The study authors also wrote that “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Cervical cancer is the second most common cancer in women worldwide. This is caused by oncogenic (cancer causing) types of human papillomavirus (HPV) infection. Although large numbers of young sexually active women become infected, only a small number develop cervical cancer. This points to different factors that cause cells in these women to either go back to normal, or go on to become cancerous. Dr. Chattopadhyay believes that some of these factors are genetic. He wrote that “host genetic factors play an important role in the outcome of such complex or multifactor diseases such as cervical cancer and are also known to regulate the rate of disease progression.” (1)
“There are 109 known different types of human papillomaviruses (HPV). They cause warts and other lesions and two in particular, HPV 16 and HPV 18, cause cancers of the cervix, anus and penis, as well as the mouth and throat. Types 6 and 11 can cause lesions and genital warts.” (3)
The CDC notes that “You can get HPV by having oral, vaginal, or anal sex with someone who has the virus. It is most commonly spread during vaginal or anal sex. HPV can be passed even when an infected person has no signs or symptoms. Anyone who is sexually active can get HPV, even if you have had sex with only one person. You also can develop symptoms years after you have sex with someone who is infected making it hard to know when you first became infected.” (4)
“We believe that individuals concerned about HPV, should take Novirin or Gene-Eden-VIR. The formula of these natural products was shown to safely and effectively reduce HPV symptoms in a post-marketing clinical study that followed FDA guidelines.” – Greg Bennett, CBCD
What Treatments are Available that Target HPV?
“There are no drugs approved against the HPV. Current treatments include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). These procedures use liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus. The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission.” (2) In contrast, Novirin and Gene-Eden-VIR were designed to target the latent HPV.
(1) Koushik Chattopadhyay “A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer” Indian J Hum Genet. 2011 Sep-Dec; 17(3): 132–144.
(2) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8
(3) Fox, M. HPV Found in Two-Thirds of Americans, Survey Finds. Published on May 20, 2014.
(4) CDC – Human Papillomavirus (HPV) – Genital HPV Infection – Fact Sheet. Last updated on March 20, 2014.
The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases.
The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.